ENTITY
Scilex

Scilex (SCLX US)

12
Analysis
Health Care • United States
Scilex Holding Company is an innovative revenue-generating company focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. Its commercial products include ZTlido® for postherpetic neuralgia, ELYXYB® for migraine, and GLOPERBA® for gout flares. The company is headquartered in Palo Alto, California, and was founded in 2019.
more
Company Event • 14 Nov 2026 05:00 • Upcoming
Add To Calendar

Q3 2026

Company Event • 14 Aug 2026 19:00 • Upcoming
Add To Calendar

Q2 2026

Company Event • 25 Jun 2026 00:00 • Latest

AGM 2026

Company Event • 02 Jun 2026 20:00 • Upcoming
Add To Calendar

Registration filing

Company Event • 20 May 2026 20:00 • Upcoming
Add To Calendar

Q1 2026

x